The estimated Net Worth of Thomas Gad is at least $30,277,568.00. Thomas Gad owns over 614,000 units of Y-mAbs Therapeutics, Inc. stock worth over $30,277,568.00.
| Transaction Date | Company | Shares | Type | Owned | Price | Value | Post Value |
|---|---|---|---|---|---|---|---|
| 5th January 2021 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale10b5-1 trading plan | 614,000 | $49.31 | $197,248.00 | $30,277,568.00 |
| 5th January 2021 | YMAB - Y-mAbs Therapeutics, Inc. | 7,000 | Open or private sale10b5-1 trading plan | 0 | $49.36 | $345,508.80 | $0.00 |
| 5th January 2021 | YMAB - Y-mAbs Therapeutics, Inc. | 7,000 | Exercise of derivative10b5-1 trading plan | 7,000 | $2.00 | $14,000.00 | $14,000.00 |
| 28th December 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 7,000 | Open or private sale10b5-1 trading plan | 0 | $51.98 | $363,832.70 | $0.00 |
| 28th December 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 7,000 | Exercise of derivative10b5-1 trading plan | 7,000 | $2.00 | $14,000.00 | $14,000.00 |
| 16th December 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 7,000 | Open or private sale10b5-1 trading plan | 0 | $53.01 | $371,065.10 | $0.00 |
| 16th December 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 7,000 | Exercise of derivative10b5-1 trading plan | 7,000 | $2.00 | $14,000.00 | $14,000.00 |
| 14th December 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale10b5-1 trading plan | 618,000 | $52.89 | $211,545.60 | $32,683,795.20 |
| 11th December 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 50,000 | Open or private sale | 0 | $51.17 | $2,558,640.00 | $0.00 |
| 11th December 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 50,000 | Exercise of derivative | 50,000 | $2.00 | $100,000.00 | $100,000.00 |
| 10th December 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 50,000 | Open or private sale | 0 | $50.75 | $2,537,620.00 | $0.00 |
| 10th December 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 50,000 | Exercise of derivative | 50,000 | $2.00 | $100,000.00 | $100,000.00 |
| 16th November 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale10b5-1 trading plan | 626,000 | $46.17 | $184,671.60 | $28,901,105.40 |
| 2nd November 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale10b5-1 trading plan | 630,000 | $43.69 | $174,768.80 | $27,526,086.00 |
| 15th October 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale10b5-1 trading plan | 634,000 | $39.15 | $156,603.60 | $24,821,670.60 |
| 1st October 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale10b5-1 trading plan | 638,000 | $38.88 | $155,524.40 | $24,806,141.80 |
| 15th September 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale10b5-1 trading plan | 642,000 | $40.81 | $163,224.80 | $26,197,580.40 |
| 11th April 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 150,000 | Open or private sale | 940,000 | $25.80 | $3,870,000.00 | $24,252,000.00 |
| 9th April 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 800 | Open or private sale | 1,090,000 | $26.93 | $21,545.28 | $29,355,444.00 |
| 9th April 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 99,200 | Open or private sale | 1,090,800 | $26.02 | $2,581,184.00 | $28,382,616.00 |
| 13th May 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 6,000 | Open or private sale | 934,000 | $20.61 | $123,647.40 | $19,247,778.60 |
| 28th May 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 6,000 | Open or private sale | 928,000 | $20.21 | $121,252.20 | $18,753,673.60 |
| 3rd June 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 924,000 | $20.03 | $80,121.20 | $18,507,997.20 |
| 10th June 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 920,000 | $22.79 | $91,166.40 | $20,968,272.00 |
| 24th June 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 916,000 | $21.77 | $87,097.60 | $19,945,350.40 |
| 8th July 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 912,000 | $22.40 | $89,591.60 | $20,426,884.80 |
| 22nd July 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 908,000 | $22.54 | $90,176.80 | $20,470,133.60 |
| 5th August 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 904,000 | $21.78 | $87,105.60 | $19,685,865.60 |
| 19th August 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 900,000 | $27.70 | $110,804.80 | $24,931,080.00 |
| 3rd September 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 896,000 | $25.77 | $103,080.80 | $23,090,099.20 |
| 16th September 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 892,000 | $30.59 | $122,375.60 | $27,289,758.80 |
| 14th September 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 22,569 | Open or private sale | 0 | $41.00 | $925,426.05 | $0.00 |
| 14th September 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 22,569 | Exercise of derivative | 22,569 | $2.00 | $45,138.00 | $45,138.00 |
| 11th September 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 13,571 | Open or private sale | 0 | $40.33 | $547,330.64 | $0.00 |
| 11th September 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 13,571 | Exercise of derivative | 13,571 | $2.00 | $27,142.00 | $27,142.00 |
| 10th September 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 13,860 | Open or private sale | 0 | $41.58 | $576,359.78 | $0.00 |
| 10th September 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 13,860 | Exercise of derivative | 13,860 | $2.00 | $27,720.00 | $27,720.00 |
| 7th October 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 888,000 | $25.21 | $100,848.00 | $22,388,256.00 |
| 21st October 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 884,000 | $27.59 | $110,350.80 | $24,387,526.80 |
| 4th November 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 880,000 | $30.10 | $120,418.00 | $26,491,960.00 |
| 18th November 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 876,000 | $28.41 | $113,657.60 | $24,891,014.40 |
| 2nd December 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 872,000 | $32.48 | $129,930.40 | $28,324,827.20 |
| 16th December 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 860,000 | $31.54 | $126,176.40 | $27,127,926.00 |
| 13th December 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 8,000 | Bona fide gift | 864,000 | $0.00 | ||
| 30th December 2019 | YMAB - Y-mAbs Therapeutics, Inc. | 201 | Other acquisition or disposition | 1,030,356 | $0.00 | ||
| 13th January 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 856,000 | $30.90 | $123,612.00 | $26,452,968.00 |
| 27th January 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 852,000 | $35.06 | $140,223.60 | $29,867,626.80 |
| 10th February 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 848,000 | $33.03 | $132,120.80 | $28,009,609.60 |
| 18th February 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 844,000 | $32.78 | $131,132.80 | $27,669,020.80 |
| 2nd March 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 840,000 | $29.18 | $116,713.20 | $24,509,772.00 |
| 16th March 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 836,000 | $18.01 | $72,040.80 | $15,056,527.20 |
| 13th April 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 832,000 | $29.43 | $117,711.20 | $24,483,929.60 |
| 1st May 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 828,000 | $32.35 | $129,404.40 | $26,786,710.80 |
| 12th May 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 50,000 | Open or private sale | 778,000 | $39.04 | $1,951,935.00 | $30,372,108.60 |
| 18th May 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 774,000 | $39.65 | $158,596.00 | $30,688,326.00 |
| 27th May 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 50,000 | Open or private sale | 724,000 | $39.01 | $1,950,460.00 | $28,242,660.80 |
| 4th June 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 720,000 | $41.61 | $166,443.60 | $29,959,848.00 |
| 15th June 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 716,000 | $43.45 | $173,811.20 | $31,112,204.80 |
| 1st July 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 712,000 | $42.04 | $168,178.00 | $29,935,684.00 |
| 15th July 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 708,000 | $40.06 | $160,229.20 | $28,360,568.40 |
| 3rd August 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 704,000 | $36.51 | $146,026.00 | $25,700,576.00 |
| 12th August 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 13,000 | Open or private sale | 654,000 | $39.51 | $513,636.50 | $25,839,867.00 |
| 11th August 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 37,000 | Open or private sale | 667,000 | $40.06 | $1,482,042.40 | $26,716,818.40 |
| 17th August 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 650,000 | $40.35 | $161,392.00 | $26,226,200.00 |
| 1st September 2020 | YMAB - Y-mAbs Therapeutics, Inc. | 4,000 | Open or private sale | 646,000 | $41.60 | $166,390.40 | $26,872,049.60 |